2026 Trials on Neurodegenerative Benefits: Alzheimers and Parkinsons: The Neurodegenerative B12 Study (phase 2, n=1,000, NIA 2025) investigates 1,000-5,000 mcg IM doses, with preliminary 2025 data showing a 10-15% reduction in cognitive decline (MMSE +1-2 points) and 5-10% lower tau protein levels in MCI patients
Dairy products such as fish, milk, poultry, eggs, and meat are the main sources of B12
No artificial blue color added
Thank you!"..." more
Furthermore, B12 injections have gained popularity among those seeking to achieve weight loss goals
Most treatment protocols involve weekly injections over a course of 4 to 12 weeks